Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about major depressive disorder
Recent news which mentions major depressive disorder
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
November 14, 2024
Tickers
CMPS
NEWS
Tags
major depressive disorder
Food and Drug Administration (FDA)
CaaMTech Inc/
From
Benzinga
Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
November 13, 2024
Tickers
CYBN
Tags
CYBN
Benzinga
CYB003
From
Benzinga
Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder
June 20, 2024
Tickers
NEWS
Tags
Cannabis
major depressive disorder
News
From
Benzinga
LSD Microdosing For Depression? This Clinical Study Reveals Promising Results
February 26, 2024
Tickers
NEWS
Tags
News
LSD Microdosing
major depressive disorder
From
Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
November 01, 2023
Tickers
CYBN
Tags
Benzinga
CYBN
Psychedelic/Assisted Therapies
From
Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
October 03, 2023
Tickers
CYBN
Tags
Cannabis
Benzinga
CYBN
From
Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
September 26, 2023
Tickers
CYBN
DMTTF
Tags
Market News
Psychedelic/Assisted Therapies
Management
From
Benzinga
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
September 21, 2023
Tickers
CYBN
DMTTF
Tags
CYBN
Benzinga
Market News
From
Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
September 03, 2023
Tags
Cannabis
Global
Guidance
From
Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
Tags
Psychedelic/Assisted Therapies
Market News
Benzinga
From
Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
April 17, 2023
Tickers
MNMD
Tags
LSD Therapy
major depressive disorder
Penny Stocks
From
Benzinga
Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder
April 14, 2023
Tickers
CMPS
Tags
major depressive disorder
Sunstone Therapies
News
From
Benzinga
DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial
April 04, 2023
Tickers
DMTTF
Tags
Psychedelic/Assisted Therapies
Market News
Psychedelics
From
Benzinga
FSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive Disorder
March 23, 2023
Tickers
HUGE
Tags
Penny Stocks
Cannabis
major depressive disorder
From
Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
March 08, 2023
Tickers
DMTTF
Tags
DMTTF
Psychedelics
Short/Acting Psychedelics
From
Benzinga
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
January 31, 2023
Tickers
CMND
Tags
Markets
News
major depressive disorder
From
Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
January 25, 2023
Tickers
DMTTF
Tags
Market News
Benzinga
DMT Entities
From
Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
December 22, 2022
Tickers
DMTTF
Tags
Cannabis
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
December 19, 2022
Tickers
DMTTF
Tags
Legal
DMT/Assisted Therapy
DMTTF
From
Benzinga
FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder
December 16, 2022
Tickers
EHVVF
Tags
major depressive disorder
Penny Stocks
News
From
Benzinga
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
October 13, 2022
Tickers
RLMD
Tags
Small Cap
Trading Ideas
General
From
Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers
MSSTF
Tags
major depressive disorder
Clerkenwell Health
Penny Stocks
From
Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
August 30, 2022
Tickers
CYBN
Tags
Health Care
Psychedelics
Markets
From
Benzinga
New Zealand Government Grants $650K For LSD Microdosing Trials
July 25, 2022
Tickers
BLRZF
Tags
News
Markets
Penny Stocks
From
Benzinga
How To Enroll In A Psychedelic Clinical Trial In 5 Easy Steps
April 29, 2022
Tags
Benzinga
contributors
PTSD
From
Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
March 04, 2022
Tags
Market News
John Hopkins University
psychedelics
From
Benzinga
Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
December 01, 2021
Tickers
BIIB
SAGE
Tags
News
Biotech
major depressive disorder
From
Benzinga
AbbVie's Major Depressive Disorder Candidate Shows Mixed Result In Late-Stage Trials
October 29, 2021
Tickers
ABBV
Tags
Movers
General
Trading Ideas
From
Benzinga
B. Riley Sees 'Significant Potential' In This Beaten-Up Biotech Stock
October 21, 2021
Tickers
SAGE
SEEL
Tags
Analyst Color
General
Reiteration
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.